Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Serum IFN-λ1 protein by presence or absence of SLE clinical characteristics

From: Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity

Clinical characteristics Present
n Median (interquartile range)
Absent
n Median (interquartile range)
P-
value
Alopecia 16 297.839 (415.787 to 193.064) 26 305.489 (368.886 to 267.957) NS
Mucosal ulcer 10 307.276 (432.756 to 194.393) 32 300.582 (369.881 to 261.142) NS
Malar rash 26 299.715 (381.168 to 245.771) 16 310.309 (400.762 to 260.412) NS
Fever 10 300.520 (340.477 to 237.890) 32 305.487 (410.534 to 263.343) NS
Chest affection 2 385.455 (440.400 to 330.510) 40 300.522 (371.396 to 260.412) NS
Renal disease 25 330.060 (416.827 to 289.660) 17 270.400 (315.764 to 172.973) 0.0368
Neurological disorder 2 246.952 (298.846 to 195.058) 40 305.488 (400.033 to 261.142) NS
Arthritis 29 330.060 (421.041 to 283.616) 13 265.347 (301.716 to 183.47) 0.0097
Anemia 12 307.276 (422.614 to 211.962) 30 300.582 (368.886 to 260.557) NS
Thrombocytopenia 8 300.520 (330.398 to 192.99) 34 305.488 (409.822 to 262.164) NS
Leucopenia 22 308.144 (411.573 to 245.771) 20 300.520 (360.412 to 260.412) NS
  1. NS, not significant.